JGC
ITCI
J. Goldman & Co’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-106,080
| Closed | -$7.6M | – | 416 |
|
|
2023
Q4 | $7.6M | Buy |
+106,080
| New | +$7.6M | 0.31% | 72 |
|
|
2023
Q3 | – | Sell |
-55,595
| Closed | -$3.52M | – | 385 |
|
|
2023
Q2 | $3.52M | Buy |
+55,595
| New | +$3.52M | 0.13% | 110 |
|
|
2022
Q1 | – | Sell |
-7,585
| Closed | -$397K | – | 356 |
|
|
2021
Q4 | $397K | Sell |
7,585
-17,057
| -69% | -$893K | 0.02% | 222 |
|
|
2021
Q3 | $919K | Sell |
24,642
-41,590
| -63% | -$1.55M | 0.05% | 185 |
|
|
2021
Q2 | $2.7M | Sell |
66,232
-63,800
| -49% | -$2.6M | 0.1% | 153 |
|
|
2021
Q1 | $4.41M | Buy |
130,032
+706
| +0.5% | +$24K | 0.14% | 116 |
|
|
2020
Q4 | $4.11M | Buy |
+129,326
| New | +$4.11M | 0.21% | 96 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 317 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 290 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 265 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 261 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 251 |
|
|
2018
Q1 | – | Sell |
-249,274
| Closed | -$3.61M | – | 341 |
|
|
2017
Q4 | $3.61M | Buy |
249,274
+138,374
| +125% | +$2M | 0.19% | 80 |
|
|
2017
Q3 | $1.75M | Buy |
110,900
+26,700
| +32% | +$421K | 0.09% | 116 |
|
|
2017
Q2 | $1.05M | Buy |
+84,200
| New | +$1.05M | 0.06% | 122 |
|
|
2016
Q4 | – | Sell |
-25,000
| Closed | -$381K | – | 300 |
|
|
2016
Q3 | $381K | Buy |
+25,000
| New | +$381K | 0.02% | 169 |
|